Collaborations Pharmaceuticals and UTMB awarded a $1,999,195 contract for Pyronaridine as an oral Treatment for Ebola
Collaborations Pharmaceuticals, Inc. and the University of Texas Medical Branch will perform preclinical in vivo studies on a potential treatment for Ebola. RALEIGH, NC, UNITED STATES, November 19, 2025 /EINPresswire.com/ -- Collaborations …